Majdi Al-Hasan to Bacteremia
This is a "connection" page, showing publications Majdi Al-Hasan has written about Bacteremia.
Connection Strength
12.674
-
Evaluation of early clinical failure criteria in Enterococcus species bloodstream infection. Infection. 2022 Aug; 50(4):873-877.
Score: 0.686
-
Prediction of mortality in Staphylococcus aureus bloodstream infection using quick Pitt bacteremia score. J Infect. 2022 02; 84(2):131-135.
Score: 0.681
-
Resilience of the Pitt Bacteremia Score: 3 Decades and Counting. Clin Infect Dis. 2020 04 15; 70(9):1834-1836.
Score: 0.607
-
Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors. J Glob Antimicrob Resist. 2020 09; 22:87-93.
Score: 0.594
-
Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections. Clin Infect Dis. 2019 07 18; 69(3):414-420.
Score: 0.576
-
Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates. Int J Antimicrob Agents. 2019 Jul; 54(1):1-7.
Score: 0.563
-
Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection. Infection. 2019 Aug; 47(4):571-578.
Score: 0.559
-
Duration of Antimicrobial Therapy for Enterobacteriaceae Bacteremia: Using Convenient End Points for Convenient Conclusions. Clin Infect Dis. 2018 06 01; 66(12):1978-1979.
Score: 0.533
-
Reply to comments: duration of antimicrobial therapy for Gram-negative bacteremia secondary to urinary source of infection. Infection. 2018 04; 46(2):283-284.
Score: 0.522
-
Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection. 2017 Oct; 45(5):613-620.
Score: 0.495
-
Clinical Risk Score for Prediction of Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates. Infect Control Hosp Epidemiol. 2017 03; 38(3):266-272.
Score: 0.482
-
Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother. 2017 01; 72(1):299-304.
Score: 0.475
-
Differential effect of prior ?-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2017 Jan; 87(1):87-91.
Score: 0.474
-
Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections. Int J Antimicrob Agents. 2016 Nov; 48(5):498-503.
Score: 0.471
-
Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae. Am J Infect Control. 2016 12 01; 44(12):1611-1616.
Score: 0.470
-
Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob Agents Chemother. 2016 Apr; 60(4):2265-72.
Score: 0.458
-
Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis. Antimicrob Agents Chemother. 2015 Jan; 59(1):245-50.
Score: 0.416
-
Bloodstream infections and central line-associated bloodstream infections. Surg Clin North Am. 2014 Dec; 94(6):1233-44.
Score: 0.413
-
Impact of Gram-negative bloodstream infection on long-term allograft survival after kidney transplantation. Transplantation. 2011 Jun 15; 91(11):1206-10.
Score: 0.329
-
Cefepime effectiveness in Gram-negative bloodstream infections. J Antimicrob Chemother. 2011 May; 66(5):1156-60.
Score: 0.323
-
Recurrent gram-negative bloodstream infection: a 10-year population-based cohort study. J Infect. 2010 Jul; 61(1):28-33.
Score: 0.303
-
Epidemiology and outcome of Klebsiella species bloodstream infection: a population-based study. Mayo Clin Proc. 2010 Feb; 85(2):139-44.
Score: 0.299
-
Bacteremia complicating gram-negative urinary tract infections: a population-based study. J Infect. 2010 Apr; 60(4):278-85.
Score: 0.299
-
Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007. J Antimicrob Chemother. 2009 Jul; 64(1):169-74.
Score: 0.285
-
Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. Antimicrob Agents Chemother. 2009 Apr; 53(4):1386-94.
Score: 0.279
-
Incidence of Pseudomonas aeruginosa bacteremia: a population-based study. Am J Med. 2008 Aug; 121(8):702-8.
Score: 0.270
-
Invasive enteric infections in hospitalized patients with underlying strongyloidiasis. Am J Clin Pathol. 2007 Oct; 128(4):622-7.
Score: 0.255
-
Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation. Pharmacotherapy. 2023 01; 43(1):85-95.
Score: 0.184
-
Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity. Pharmacotherapy. 2018 01; 38(1):42-50.
Score: 0.129
-
Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections. Antimicrob Agents Chemother. 2017 05; 61(5).
Score: 0.123
-
Non-tuberculous mycobacterial bloodstream infections in patients with indwelling vascular catheters - the role of sickle cell anaemia. Infect Dis (Lond). 2017 May; 49(5):341-346.
Score: 0.120